DnB Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.03M | Sell |
30,942
-1,249
| -4% | -$259K | 0.02% | 443 |
|
|
2026
Q1 | $7.23M | Buy |
32,191
+1,951
| +6% | +$486K | 0.03% | 364 |
|
|
2025
Q4 | $7.28M | Buy |
30,240
+1,664
| +6% | +$426K | 0.03% | 359 |
|
|
2025
Q3 | $7.82M | Buy |
28,576
+959
| +3% | +$262K | 0.03% | 340 |
|
|
2025
Q2 | $7.13M | Buy |
27,617
+996
| +4% | +$238K | 0.03% | 323 |
|
|
2025
Q1 | $5.96M | Sell |
26,621
-81
| -0.3% | -$18.9K | 0.03% | 346 |
|
|
2024
Q4 | $6.11M | Buy |
26,702
+1,729
| +7% | +$416K | 0.03% | 350 |
|
|
2024
Q3 | $6.1M | Buy |
24,973
+924
| +4% | +$206K | 0.03% | 356 |
|
|
2024
Q2 | $4.6M | Buy |
24,049
+938
| +4% | +$190K | 0.02% | 365 |
|
|
2024
Q1 | $4.58M | Sell |
23,111
-2,919
| -11% | -$535K | 0.02% | 367 |
|
|
2023
Q4 | $4.48M | Sell |
26,030
-203
| -0.8% | -$31.2K | 0.02% | 388 |
|
|
2023
Q3 | $3.88M | Buy |
26,233
+383
| +1% | +$69.3K | 0.02% | 402 |
|
|
2023
Q2 | $5.65M | Sell |
25,850
-383
| -1% | -$85.4K | 0.03% | 336 |
|
|
2023
Q1 | $5.74M | Buy |
26,233
+1,059
| +4% | +$230K | 0.04% | 335 |
|
|
2022
Q4 | $5.24M | Sell |
25,174
-303
| -1% | -$66.6K | 0.04% | 341 |
|
|
2022
Q3 | $5.56M | Sell |
25,477
-535
| -2% | -$122K | 0.04% | 314 |
|
|
2022
Q2 | $5.45M | Buy |
26,012
+642
| +3% | +$137K | 0.04% | 315 |
|
|
2022
Q1 | $6.15M | Buy |
25,370
+1,662
| +7% | +$402K | 0.04% | 328 |
|
|
2021
Q4 | $6.18M | Buy |
23,708
+730
| +3% | +$189K | 0.04% | 327 |
|
|
2021
Q3 | $6.06M | Buy |
22,978
+350
| +2% | +$95.7K | 0.04% | 311 |
|
|
2021
Q2 | $5.58M | Buy |
22,628
+774
| +4% | +$163K | 0.04% | 349 |
|
|
2021
Q1 | $4.24M | Buy |
21,854
+2,105
| +11% | +$422K | 0.03% | 367 |
|
|
2020
Q4 | $4.2M | Buy |
19,749
+1,343
| +7% | +$268K | 0.04% | 304 |
|
|
2020
Q3 | $3.16M | Buy |
18,406
+712
| +4% | +$131K | 0.03% | 306 |
|
|
2020
Q2 | $3.4M | Buy |
17,694
+2,321
| +15% | +$380K | 0.04% | 273 |
|
|
2020
Q1 | $2.26M | Sell |
15,373
-1,106
| -7% | -$176K | 0.03% | 309 |
|
|
2019
Q4 | $2.55M | Buy |
16,479
+1,823
| +12% | +$263K | 0.03% | 401 |
|
|
2019
Q3 | $1.98M | Buy |
14,656
+807
| +6% | +$106K | 0.02% | 420 |
|
|
2019
Q2 | $1.69M | Sell |
13,849
-924
| -6% | -$102K | 0.02% | 444 |
|
|
2019
Q1 | $1.54M | Sell |
14,773
-5,154
| -26% | -$532K | 0.02% | 472 |
|
|
2018
Q4 | $2.27M | Buy |
19,927
+1,882
| +10% | +$202K | 0.03% | 351 |
|
|
2018
Q3 | $2.08M | Buy |
18,045
+2,745
| +18% | +$301K | 0.02% | 396 |
|
|
2018
Q2 | $1.58M | Buy |
15,300
+800
| +6% | +$80.9K | 0.02% | 441 |
|
|
2018
Q1 | $1.43M | Buy |
14,500
+1,600
| +12% | +$151K | 0.02% | 450 |
|
|
2017
Q4 | $1.09M | Hold |
12,900
| – | – | 0.01% | 487 |
|
|
2017
Q3 | $993K | Hold |
12,900
| – | – | 0.01% | 475 |
|
|
2017
Q2 | $1M | Sell |
12,900
-600
| -4% | -$42.9K | 0.01% | 456 |
|
|
2017
Q1 | $972K | Buy |
13,500
+3,000
| +29% | +$207K | 0.02% | 459 |
|
|
2016
Q4 | $652K | Buy |
10,500
+100
| +1% | +$6.13K | 0.01% | 475 |
|
|
2016
Q3 | $674K | Buy |
10,400
+400
| +4% | +$26.6K | 0.01% | 444 |
|
|
2016
Q2 | $632K | Hold |
10,000
| – | – | 0.01% | 436 |
|
|
2016
Q1 | $578K | Sell |
10,000
-7,300
| -42% | -$413K | 0.01% | 445 |
|
|
2015
Q4 | $929K | Sell |
17,300
-9,500
| -35% | -$535K | 0.02% | 329 |
|
|
2015
Q3 | $1.37M | Buy |
26,800
+13,600
| +103% | +$732K | 0.03% | 265 |
|
|
2015
Q2 | $744K | Sell |
13,200
-900
| -6% | -$56.8K | 0.02% | 370 |
|
|
2015
Q1 | $1.01M | Sell |
14,100
-25,300
| -64% | -$1.64M | 0.02% | 346 |
|
|
2014
Q4 | $2.21M | Buy |
+39,400
| New | +$2.06M | 0.05% | 216 |
|
Other funds holding RMD
DnB Asset Management's RMD Position: Q2 2026 in Review
DnB Asset Management reduced its ResMed (RMD) stake by 3.9% in Q2 2026, selling an estimated $259K and leaving 30,942 shares worth $6.03M. The position accounts for 0.02% of the portfolio, ranked #443.
DnB Asset Management first reported a position in RMD in Q4 2014 and has held it in 47 quarters since. The position peaked at $7.82M in Q3 2025. 575 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- DnB Asset Management held 30,942 shares of ResMed worth $6.03M as of Q2 2026.
- DnB Asset Management sold 1,249 ResMed shares in Q2 2026, an estimated $259K.
- ResMed made up 0.02% of DnB Asset Management's portfolio in Q2 2026, its #443 holding.
- DnB Asset Management first reported a position in ResMed in Q4 2014 and has held it in 47 quarters since.
- DnB Asset Management's ResMed position peaked at $7.82M in Q3 2025.
- 575 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.